Supplier
Whitley Memorial Hospital, INC.
Whitley Memorial Hospital, INC. was paid $9.54M by Medicaid between Jan 2018 and Nov 2024, across 85 billing codes. Its largest line is 99283, emergency room visit (moderate) — 60% of everything it billed.
33Billing provider infoWHITLEY MEMORIAL HOSPITAL, INC.
COLUMBIA CITY, IN 46725
COLUMBIA CITY, IN 46725
33aNPI1205844495assigned 08/03/2006
33bProvider typeInstitutional Pharmacy
28Total paid$9.54M
24GClaims162,052
24DCodes billed85
24AFirst – last monthJan 2018 – Nov 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RISSER, STANTON controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,620 | $595K | |
| 2019 | 21,111 | $899K | |
| 2020 | 16,315 | $937K | |
| 2021 | 23,198 | $1.51M | |
| 2022 | 32,665 | $2.46M | |
| 2023 | 29,928 | $2.10M | |
| 2024incomplete | 12,215 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 60% | 33,639 | 29,551 | $5.75M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 12,548 | 10,372 | $1.88M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.4% | 5,170 | 4,109 | $328K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.5% | 3,606 | 3,134 | $236K |
| 71045 | Radiologic examination, chest; single view | 2.4% | 1,782 | 1,393 | $231K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 1,140 | 1,058 | $143K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.5% | 572 | 475 | $141K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 3,993 | 3,373 | $113K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,870 | 18,107 | $94K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 19,279 | 15,283 | $86K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,240 | 1,049 | $85K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 708 | 629 | $66K |
73 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 22,462 | $45K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 99 | $34K |
| 80076 | <1% | 5,860 | $26K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,079 | $22K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 275 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 635 | $17K |
| 99217 | <1% | 56 | $15K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 213 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 2,097 | $13K |
| 84484 | <1% | 1,925 | $13K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 118 | $12K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 28 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 311 | $11K |
| 81001 | <1% | 5,638 | $10K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 112 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 387 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 278 | $8K |
| 99219 | <1% | 19 | $8K | |
| 80061 | Lipid panel | <1% | 870 | $8K |
| 99221 | <1% | 15 | $8K | |
| 83735 | <1% | 2,230 | $7K | |
| 83690 | <1% | 2,496 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 617 | $7K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 49 | $6K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 148 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 401 | $4K |
| 85027 | <1% | 1,191 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 216 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,025 | $4K |
| 87634 | <1% | 61 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 543 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 394 | $3K |
| 81025 | <1% | 438 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 199 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 39 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 30 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 44 | $1K |
| 87081 | <1% | 249 | $973.41 | |
| 84703 | <1% | 198 | $843.94 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 19 | $810.81 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $456.17 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $456.17 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 141 | $442.26 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 18 | $442.26 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16 | $388.68 |
| 81003 | <1% | 280 | $317.89 | |
| 82553 | <1% | 91 | $301.31 | |
| 83605 | <1% | 52 | $288.62 | |
| 82550 | <1% | 96 | $276.04 | |
| 74022 | <1% | 30 | $253.28 | |
| 87480 | <1% | 13 | $252.64 | |
| 87510 | <1% | 13 | $252.64 | |
| 87660 | <1% | 13 | $252.64 | |
| 85379 | <1% | 33 | $232.06 | |
| 82043 | <1% | 53 | $159.89 | |
| 80047 | <1% | 16 | $114.62 | |
| 83550 | <1% | 14 | $110.76 | |
| 82962 | <1% | 29 | $95.39 | |
| 82077 | <1% | 14 | $83.75 | |
| 83540 | <1% | 14 | $82.02 | |
| 87040 | <1% | 21 | $77.91 | |
| 87077 | <1% | 30 | $66.54 | |
| 86592 | <1% | 14 | $53.82 | |
| 85610 | <1% | 66 | $27.28 | |
| 85652 | <1% | 17 | $23.58 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 270 | $4.90 |
| 93041 | <1% | 16 | $4.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 408 | $0.00 |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 0% | 85 | $0.00 |
| A0425 | Ground mileage, per statute mile | 0% | 1,188 | $0.00 |
| A0429 | Emergency ambulance ride, basic life support | 0% | 217 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 44 | $0.00 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 0% | 101 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRISSER, STANTON (ACFO)
Parent organizationWHITLEY MEMORIAL HOSPITAL, INC.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.